EPLAW PATENT BLOG

NL – Asestek v. Coolergiant Computer

Posted: December 1st, 2017

Asestek A/S v. Coolergiant Computer Handels GmbH, District Court The Hague, The Netherlands, 29 November 2017, Case No. ECLI:NL:RBDHA:2017:13715 Asestek holds a European patent related to “a cooling system for a computer system”. The Dutch part of the EP was invalidated earlier in a decision between Asestek and Cooler Master (that decision can be read […]

READ MORE

UK – GSK v. Wyeth

Posted: November 23rd, 2017

Glaxosmithkline UK Limited v Wyeth Holdings LLC, High Court, London, UK, 13 January 2017, Neutral Citation Number: [2017] EWHC 91 (Pat) This is a judgment from Henry Carr J on preliminary issues relating to the remedies available to Wyeth (referred to as its parent company, Pfizer) for infringement of its patent by GSK. The key […]

READ MORE

UK – Actavis v. ICOS

Posted: November 23rd, 2017

In Actavis v ICOS Lewison, Kitchen and Floyd LLJ held that ICOS’s patent EP (UK) 1,173,181 was invalid for obviousness overturning the first instance decision of Birss J. That decision by the Court of Appeal led to Eli Lilly (the marketing partner of ICOS for tadalafil/Cialis) applying to the Patents Court for an interim injunction […]

READ MORE

FR – Applying statutes of limitations to patent revocations in France

Posted: November 9th, 2017

Applying statutes of limitations to patent revocations in France: Running solves nothing: you have to start moving at the right moment… but when? by Pauline Debré and Jean-François Merdrignac, Linklaters Paris Equity aids the vigilant, not the ones who sleep over their rights (iura vigilantibus, non dormientibus prosunt). This is also true for claimants in […]

READ MORE

ES – Shionogi & Astrazeneca v. Ratiopharm / Rosuvastatin / Interim Injunction Opposition

Posted: October 16th, 2017

Shionogi Sieyaku Kabushiki Kaisha, AstraZeneca UK Limited, AstraZeneca Farmacéutica Spain, S.A. v. Ratiopharm España, S.A., Barcelona Commercial Court No. 5, 12 July 2017, Docket No. 148/2017 In a decision rendered on 12 July 2017, Commercial Court No. 5 of Barcelona overruled its previous order of 21 February 2017, pursuant to which it granted ex parte […]

READ MORE

NL – Synthon v. Yeda

Posted: September 25th, 2017

Synthon B.V. v. Yeda Research & Development Co. Ltd, District Court The Hague, 6 September 2017, Case Number ECLI:NL:RBDHA:2017:10315 Yeda Research & Development Co., Ltd is the proprietor of EP 2 405 794, which claims a dosing regimen for glatiramer acetate (Copaxone®) for the treatment of Multiple Sclerosis. In proceedings before the District Court of […]

READ MORE

NL – High Point v. KPN / Supreme Court

Posted: September 18th, 2017

High Point SARL v. KPN B.V., Supreme Court of the Netherlands, 15 September 2017, Case no. ECLI:NL:HR:2017:2363 High Point holds EP 772 that relates to a ‘Wireless access telephone-to-telephone network interface architecture’. The Court of Appeal decided earlier that the claim limitations submitted by High Point per deed after having submitted its statement of appeal […]

READ MORE

NL – Becton Dickinson v. Braun Melsungen

Posted: September 14th, 2017

Becton Dickinson BV v. B. Braun Melsungen AG, District Court of The Hague, 6 September 2017, case no. 521541, ECLI:NL:RBDHA:2017:9997 This judgment of the District Court of The Hague concerns a nullity action lodged by Becton Dickinson B.V. against B. Braun Melsungen AG in relation to the (Dutch part of the) European patent EP 2 […]

READ MORE

NL – Smart Technologies v. CTouch Europe

Posted: August 1st, 2017

Smart Technologies ULC v. CTouch Europe B.V., District Court The Hague, 26 July 2017, Case No. ECLI:NL:RBDHA:2017:8247 Smart Technologies is the holder of a patent on smart television screens. CTouch’s Gillette defence fails as there is a theoretic and practical difference between its products and the prior art. Injunction and ancillary claims awarded. Update: CTouch […]

READ MORE